Sue Currie
Chief Operating Officer at Virion Therapeutics LLC
Profile
Sue Currie is currently the Chief Operating Officer at Virion Therapeutics LLC since 2021.
Previously, she worked as the Vice President & Head-Medical Affairs at Nektar Therapeutics.
Dr. Currie completed her undergraduate degree at the University of Saskatchewan, her graduate degree at the University of Phoenix, and her doctorate at the University of San Francisco.
Sue Currie active positions
| Companies | Position | Start |
|---|---|---|
Virion Therapeutics LLC
 Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Chief Operating Officer | 2021-11-21 |
Former positions of Sue Currie
| Companies | Position | End |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Training of Sue Currie
| University of Saskatchewan | Undergraduate Degree |
| University of Phoenix | Graduate Degree |
| University of San Francisco | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| Private companies | 1 |
|---|---|
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Health Technology |
- Stock Market
- Insiders
- Sue Currie
